688 related articles for article (PubMed ID: 28895566)
1. WNT signalling in prostate cancer.
Murillo-Garzón V; Kypta R
Nat Rev Urol; 2017 Nov; 14(11):683-696. PubMed ID: 28895566
[TBL] [Abstract][Full Text] [Related]
2. Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance.
Yeh Y; Guo Q; Connelly Z; Cheng S; Yang S; Prieto-Dominguez N; Yu X
Adv Exp Med Biol; 2019; 1210():351-378. PubMed ID: 31900917
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin signalling in prostate cancer.
Kypta RM; Waxman J
Nat Rev Urol; 2012 Aug; 9(8):418-28. PubMed ID: 22710668
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the role of Wnt/β-catenin signaling in prostate cancer.
Schneider JA; Logan SK
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):3-8. PubMed ID: 28189566
[TBL] [Abstract][Full Text] [Related]
5. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
Wang D; Lu G; Shao Y; Xu D
Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract][Full Text] [Related]
7. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
[TBL] [Abstract][Full Text] [Related]
8. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
Bisson I; Prowse DM
Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
[TBL] [Abstract][Full Text] [Related]
10. Wnt signalling and prostate cancer.
Yardy GW; Brewster SF
Prostate Cancer Prostatic Dis; 2005; 8(2):119-26. PubMed ID: 15809669
[TBL] [Abstract][Full Text] [Related]
11. TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer.
Aripaka K; Gudey SK; Zang G; Schmidt A; Åhrling SS; Österman L; Bergh A; von Hofsten J; Landström M
EBioMedicine; 2019 Jul; 45():192-207. PubMed ID: 31262711
[TBL] [Abstract][Full Text] [Related]
12. miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.
Song XL; Huang B; Zhou BW; Wang C; Liao ZW; Yu Y; Zhao SC
Biomed Pharmacother; 2018 Mar; 99():369-374. PubMed ID: 29358129
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.
Visweswaran M; Arfuso F; Dilley RJ; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2018 Feb; 95():63-72. PubMed ID: 29277675
[TBL] [Abstract][Full Text] [Related]
14. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
[TBL] [Abstract][Full Text] [Related]
15. The role of stem/progenitor cells and Wnt/β-catenin signaling pathway in the patients with prostate cancer.
Vatansever HS; Gumus B; Aydogdu O; Sivrikoz ON; Türköz-Uluer E; Kivanç M; Ateşçi YZ; Bugdayci H
Minerva Urol Nefrol; 2014 Dec; 66(4):249-55. PubMed ID: 25531194
[TBL] [Abstract][Full Text] [Related]
16. WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERT
Zhang K; Guo Y; Wang X; Zhao H; Ji Z; Cheng C; Li L; Fang Y; Xu D; Zhu HH; Gao WQ
Cancer Res; 2017 May; 77(9):2534-2547. PubMed ID: 28209613
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potency of Wnt signaling antagonists in the pathogenesis of prostate cancer, current status and perspectives.
Pashirzad M; Shafiee M; Khazaei M; Fiuji H; Ryzhikov M; Soleimanpour S; Hesari A; Avan A; Hassanian SM
J Cell Physiol; 2019 Feb; 234(2):1237-1247. PubMed ID: 30191954
[TBL] [Abstract][Full Text] [Related]
18. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
[TBL] [Abstract][Full Text] [Related]
19. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.
Verras M; Sun Z
Cancer Lett; 2006 Jun; 237(1):22-32. PubMed ID: 16023783
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor.
Zhu H; Mazor M; Kawano Y; Walker MM; Leung HY; Armstrong K; Waxman J; Kypta RM
Cancer Res; 2004 Nov; 64(21):7918-26. PubMed ID: 15520198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
